Ocular Therapeutix Sponsored Study Titled ‘Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration’ Posted To ClinicalTrials.Gov Site
https://clinicaltrials.gov/ct2/show/NCT04989699
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
Ocular Therapeutics Publishes Study Titled ‘A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects’ To ClinicalTrials.Gov Website
https://clinicaltrials.gov/ct2/show/NCT04945824
Ocular Therapeutix Reports Strategic Discovery Collaboration With Mosaic Biosciences For Treatment Of Dry Age-Related Macular Degeneration, No Terms Disclosed
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, entered into a discovery
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.
65 Biggest Movers From Yesterday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.
82 Biggest Movers From Yesterday
Gainers Genprex Inc (NASDAQ:GNPX) shares jumped 219.4% to close at $1.15 on Tuesday after the company announced that…